SNGX (SNGX) Stock Price & Analysis
SNGX (SNGX) fell 0.84% to USD 0.38 as of September 8, 2026 at 08:18 UTC, according to Nexqual real-time market data.
SNGX last closed at USD 0.38; the session ranged USD 0.38–0.38 on volume of 108,442 shares. Market capitalization is —, with a 52-week range of USD 0.28–2.98 (NCM). Source: Nexqual, September 8, 2026 at 08:18 UTC.
Key Statistics (as of September 8, 2026 at 08:18 UTC)
| Price | USD 0.38 |
|---|---|
| Change | ▼ 0.84% (down) |
| Previous Close | USD 0.38 |
| Open | USD 0.38 |
| Day Range | USD 0.38 – 0.38 |
| 52-Week Range | USD 0.28 – 2.98 |
| Volume | 108,442 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (SNGX)
Nexqual's technical model rates SNGX "SELL" based on 1 bullish and 4 bearish signals across 128 daily candles, as of September 8, 2026 at 08:18 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 50.33 (neutral) |
| vs SMA50 | Above (USD 0.38) |
| MACD | -0 (negative) |
From SNGX's Latest SEC 10-K Filing (filed 2026-03-31)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MBRX | Moleculin Biotech, Inc. | USD 0.71 | ▲ 2.29% |
| PHIO | Phio Pharmaceuticals Corp. | USD 1.08 | ▼ 4.42% |
| RKTO | Rocket One Inc. | USD 0.69 | ▲ 0.48% |
| TENX | Tenax Therapeutics, Inc. | USD 1.94 | ▲ 4.86% |
| SNOA | Sonoma Pharmaceuticals, Inc. | USD 1.33 | ▲ 2.71% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 08:18 UTC. This page is informational and not investment advice.